(Press-News.org) The use of newer drugs, a greater number of effective drugs, and a longer treatment regimen may be associated with improved survival of patients with multidrug resistant tuberculosis (MDR-TR), according to a large study by a team of international researchers published in this week's PLOS Medicine.
Global efforts to control tuberculosis are being challenged by the emergence of strains that are resistant to several antibiotics including isoniazid and rifampicin, the two most powerful, first-line (standard) anti-tuberculosis drugs—so-called multidrug resistant tuberculosis (MDR-TB). The treatment of MDR-TB is lengthy, toxic, expensive, and has mostly resulted in poor outcomes for patients. Importantly, the optimal treatment regimens for MDR-TB have not been determined and, to date, there have been no randomized controlled trials of treatments for MDR-TB.
In this study, a large group of international researchers (the Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB) combined data on outcomes of 9153 patients from 32 centers to find out more about the best way of treating MDR-TB. The researchers found that the use of certain drugs, the use of four or more effective drugs, and the duration of treatment were associated with successful patient outcomes.
The authors conclude: "This individual patient data meta-analysis of 9,153 patients suggests that treatment of MDR-TB should include a later generation quinolone, and ethionamide or prothionamide. In patients who have not received second-line drugs before, the optimal number of likely effective drugs appears to be at least four in the initial intensive phase, and at least three in the continuation phase. The duration of therapy associated with highest odds of success was 7-8.5 months for the initial intensive phase, and 25-27 months for total duration."
However, these findings should be interpreted with caution because of the limitations in the methods and type of data used in the study. The authors say: "In view of the serious limitations of these observational data, these findings should be considered to have highlighted several important questions for future clinical trials.
These questions include the role and choice of injectables (medications that have to be given by injection), the optimal duration of an injectable and total therapy, and the potential value of later generation quinolones as well as certain group 4 and group 5 drugs."
INFORMATION:
Funding: Partial funding for the assembly of individual patient data and meta-analysis was provided from the Stop TB Department of the World Health Organization, through a grant from USAID. Funding for data gathering at participating centres came from the following sources: in the State of California from the US Centers for Disease Control Cooperative Agreement Funds; in Italy from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement FP7- 223681; in Mexico (Veracruz) from the Mexican Secretariat of Health, the National Institutes of Health of the United States (A135969 and K01TW000001), the Wellcome Trust (176W009), the Howard Hughes Medical Institute (55000632), and the Mexican Council of Science and Technology: SEP 2004-C01-47499, FOSSIS 2005-2 (14475), (87332); in South Africa from the South African Medical Research Council funding. Funding was provided to the following investigators: M Bauer and D Menzies were supported by salary awards from the Fonds de Recherche en Sante de Quebec, L Shah was supported by CIHR (Canada Graduate Scholarship), Neel Gandhi received a Doris Duke Charitable Foundation Clinical Scientist Development Award. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.
Competing Interests: JR is a Consultant for bioMe´rieux. WWY has been indirectly sponsored to participate in International Conferences by GlaxoSmithKline and Pfizer in the last 3 years. CDM is on the Scientific Advisory Board for Otsuka pharmaceuticals development of OPC67683 (Delaminid), a new anti-TB compound. SK received salary support from the Eli Lilly Foundation as part of funding for the activities of Partners In Health by the Foundation's MDR-TB Partnership. This funder was not involved in the study design; collection, analysis and interpretation of data; writing of the paper; and/or decision to submit for publication. The Partners In Health project in Tomsk received funding from Mr. Tom White, the Open Society Institute, the Bill & Melinda Gates Foundation, and the Global Fund to fight AIDS, Tuberculosis and Malaria. None of these funders were involved in the study design; collection, analysis and interpretation of data; writing of the paper; and/or decision to submit for publication. KD is an unpaid, volunteer member of the New Diagnostics Working Group (NDWG), formed of members of the Stop TB Partnership. The Secretariat of the NDWG is hosted by FIND (Foundation for New Innovative Diagnostics). JB was working as consultant for Otsuka Pharmaceutical for the implementation of clinical trial in Peru. JB was co PI of a NIH grant in Peru, Epidemiology of Tuberculosis. MP and GP are members of the Editorial Board of PLOS Medicine. All other authors have declared that no competing interests exist.
Citation: Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, et al. (2012) Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients. PLoS Med 9(8): e1001300. doi:10.1371/journal.pmed.1001300
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER (THIS LINK WILL BECOME LIVE WHEN THE EMBARGO LIFTS):
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001300
CONTACT:
Dick Menzies
Montreal Chest Institute
McGill University, Montreal, Canada
Dick.Menzies@McGill.ca
Phone 1-514-934-1934 - ext 32128
END
Increasingly humanitarian organizations will find themselves responding to health emergencies provoked by the adverse effects of mining and other extractive industries, setting up a potential clash to do with the core principles and values at the heart of humanitarian medicine, writes Philippe Calain from the humanitarian medical organization, Médecins Sans Frontières (MSF), in this week's PLOS Medicine.
"A pragmatic approach of engagement with the corporate sector for the delivery of aid, or an implicit support to mainstream development agendas could compromise the ...
In their August editorial, the PLOS Medicine Editors reflect on a recent Policy Forum article by Jason Corburn and Alison Cohen*, which describes the need for urban health equity indicators to guide public health policy in cities and urban areas. The Editors focus on the need for better air quality data for the world's cities because many cities with the worst airborne particulate levels are in low- and middle-income countries and often have limited data. Worryingly, the World Health Organization estimates that 1.34 million premature deaths were at attributable to outdoor ...
Child mortality is a key indicator not only of child health and nutrition but also of the implementation of child survival interventions and, more broadly, of social and economic development. Millennium Development Goal 4 calls for a two thirds reduction in the under-five mortality rate between 1990 and 2015. With the renewed focus on child survival, tracking of progress in the reduction of child mortality is increasingly important. A sponsored collection of new articles on the methodology for estimation of child mortality was published today in the open-access journal ...
Researchers at the University of Hawaii – Manoa (UHM) School of Ocean and Earth Science and Technology (SOEST) made a discovery that challenges a major theory in the field of coral reef ecology. The general assumption has been that the more flexible corals are, regarding which species of single celled algae (Symbiodinium) they host in coral tissues, the greater ability corals will have to survive environmental stress. In their paper published August 29, 2012, however, scientists at the Hawaii Institute of Marine Biology (HIMB) at SOEST and colleagues documented that the ...
Scientists have taken a step closer to solving one of life's mysteries – why family size generally falls as societies become richer.
Evolutionary biologists have long puzzled over this because natural selection is expected to have selected for organisms that try to maximise their reproduction. But in industrialised societies around the world, increasing wealth coincides with people deliberately limiting their family size – the so-called 'demographic transition'.
In a study published in Proceedings of the Royal Society B: Biological Sciences, researchers from the London ...
Astronomers at the International Astronomical Union meeting announced the discovery of the first transiting circumbinary multi-planet system: two planets orbiting around a pair of stars. The discovery shows that planetary systems can form and survive even in the chaotic environment around a binary star. And such planets can exist in the habitable zone of their stars. "Each planet transits over the primary star, giving unambiguous evidence that the planets are real," said Jerome Orosz, Associate Professor of Astronomy at San Diego State University and lead author of the ...
Fort Davis, Texas — NASA's Kepler mission has found the first multi-planet solar system orbiting a binary star, characterized in large part by University of Texas at Austin astronomers using two telescopes at the university's McDonald Observatory in West Texas. The finding, which proves that whole planetary systems can form in a disk around a binary star, is published in the August 28 issue of the journal Science.
"It's Tatooine, right?" said McDonald Observatory astronomer Michael Endl. "But this was not shown in Star Wars," he said, referring to the periodic changes ...
There are more than 400,000 species of beetles and only two species of the tuatara, a reptile cousin of snakes and lizards that lives in New Zealand. Crocodiles and alligators, while nearly 250 million years old, have diversified into only 23 species. Why evolution has produced "winners" — including mammals and many species of birds and fish — and "losers" is a major question in evolutionary biology.
Scientists have often posited that because some animal and plant lineages are much older than others, they have had more time to produce new species (the dearth of crocodiles ...
Gravitational waves, much like the recently discovered Higgs boson, are notoriously difficult to observe. Scientists first detected these ripples in the fabric of space-time indirectly, using radio signals from a pulsar-neutron star binary system. The find, which required exquisitely accurate timing of the radio signals, garnered its discoverers a Nobel Prize. Now a team of astronomers has detected the same effect at optical wavelengths, in light from a pair of eclipsing white dwarf stars.
"This result marks one of the cleanest and strongest detections of the effect of ...
VIDEO:
An animation of satellite observations from August 26-28, 2012 shows Tropical Storm Isaac moving past the Florida Keys and into the Gulf of Mexico, nearing landfall in the U.S. Gulf...
Click here for more information.
NASA satellites have been providing valuable data to forecasters at the National Hurricane Center watching the development and progression of powerful Tropical Storm Isaac as it heads for landfall.
The Moderate Resolution Imaging Spectroradiometer ...
